Exiqon A/S announces U.S. subsidiary name change from

Exiqon A/S announces U.S. subsidiary name change from Oncotech, Inc. to Exiqon
Diagnostics, Inc. 

Exiqon today announces the adoption of the name Exiqon Diagnostics for its U.S.
subsidiary to signal the company's commitment to expanding its business to a
broad offering in molecular and cellular-based diagnostics that guide treatment
decisions in oncology. 

Read full Press Release in the attached pdf-document.

Exiqon A/S announces U.S. subsidiary name change from Oncotech, Inc. to Exiqon Diagnostics, Inc.

Attachments